Dynamic revenues nearly cut in half

Article

Dynamic revenues nearly cut in halfDynamic Healthcare Technologies blamed slow market reaction to new product introductions and continued delays in sales cycles for a disappointing first quarter. Revenues declined during the period by 44%.For

Dynamic revenues nearly cut in half

Dynamic Healthcare Technologies blamed slow market reaction to new product introductions and continued delays in sales cycles for a disappointing first quarter. Revenues declined during the period by 44%.

For the quarter (end-March), revenues were $6 million, compared with $10.7 million reported in the 1997 first quarter. The Maitland, FL-based company had a net loss of $2.9 million, compared with net income of $3 million in the same period last year.

Dynamic is experiencing prolonged sales cycles and contract closings, a trend the company believes is temporary. In addition, the company was hurt by a time lag between implementation of its new technology at initial sites and the ability of those sites to demonstrate the value of the technology, according to the company.

In any event, Dynamic is in the midst of a corporate streamlining and functional reorganization plan, which the company expects will result in a number of benefits such as more cost-effective operations and consistent delivery of products and solutions. The plan, which has a cost-reduction target of 20%, will continue through the second quarter.

In other company news, Dynamic has signed a loan commitment from a commercial bank for a $5 million revolving line of credit and a $200,000 guidance line of credit. The lender's obligation to close on the two lines of credit is conditioned upon conducting a satisfactory pre-closing audit and a company infusion of cash equity of $2.8 million on terms satisfactory to the lender.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.